Drug profile · INN
etomidate
ETOMIDATE
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
etomidate (ETOMIDATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12171837
Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates
granted -
US 12030911
Synthesis and biological activity of phosphoramidimidate and phosphoramidate DNA
granted -
US 11746124
Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates
granted -
US 11161873
Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates
granted -
US 11021454
Type of aryl benzofuran amidated derivative and medical use thereof
granted -
US 10570185
Method to detect autoantibody reactivity for deamidated insulin autoantigen in diabetes
granted -
US 9351989
Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
granted -
US 8916538
Solid forms of a thiophosphoramidate nucleotide prodrug
granted
Frequently asked questions
What is etomidate?
etomidate (ETOMIDATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for etomidate?
ETOMIDATE is a marketed brand name for etomidate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of etomidate?
etomidate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.